Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
AKTIENPREIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionVan Strum & Towne Inc.
Latest Disclosed Ownership16,392 shares
Latest Disclosed Value $ 994,175
Van Strum & Towne Inc. ownership in BRM / Bristol-Myers Squibb Company

On May 7, 2026 - Van Strum & Towne Inc. filed a 13F-HR form disclosing ownership of 16,392 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $859,269 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 16,392 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.00% during the quarter. The current value of the position is $777,555 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,392 0 0.00 994 12.44 0.2902
2026-02-03 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,392 0 0.00 884 19.62 0.2473
2025-10-31 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,392 0 0.00 739 -2.51 0.2172
2025-07-25 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,392 0 0.00 759 -24.12 0.2395
2025-05-06 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,392 -700 -4.10 1,000 3.42 0.3359
2025-02-10 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 17,092 450 2.70 967 12.20 0.3402
2024-11-12 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,642 0 0.00 861 24.60 0.2981
2024-07-25 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,642 0 0.00 691 -23.39 0.2509
2024-05-03 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,642 -1,000 -5.67 902 -0.33 0.3296
2024-01-19 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 17,642 0 0.00 905 -11.53 0.3547
2023-11-08 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,642 0 0.00 1,024 -9.31 0.4320
2023-08-09 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,642 0 0.00 1,128 -7.24 0.4668
2023-05-11 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 17,642 -40 -0.23 1,217 -4.40 0.5199
2023-02-01 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 17,682 0 0.00 1,272 1.19 0.5477
2022-11-14 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,682 0 0.00 1,257 -7.71 0.5803
2022-08-11 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,682 -100 -0.56 1,362 4.93 0.5803
2022-05-10 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 17,782 -322 -1.78 1,298 14.97 0.4858
2022-02-08 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 18,104 0 0.00 1,129 5.42 0.4091
2021-11-12 2021-09-30 13F Bristol-Myers Squibb COM 110122108 18,104 0 0.00 1,071 -11.49 0.4220
2021-08-06 2021-06-30 13F Bristol-Myers Squibb COM 110122108 18,104 0 0.00 1,210 5.86 0.5794
2021-05-05 2021-03-31 13F Bristol-Myers Squibb COM 110122108 18,104 1,000 5.85 1,143 7.73 0.5770
2021-02-03 2020-12-31 13F Bristol-Myers Squibb COM 110122108 17,104 7,250 73.57 1,061 78.62 0.5899
2020-11-12 2020-09-30 13F Bristol-Myers Squibb COM 110122108 9,854 0 0.00 594 2.59 0.3856
2020-07-14 2020-06-30 13F Bristol-Myers Squibb COM 110122108 9,854 0 0.00 579 5.46 0.4033
2020-04-29 2020-03-31 13F Bristol-Myers Squibb COM 110122108 9,854 0 0.00 549 -13.27 0.4345
2020-01-29 2019-12-31 13F Bristol-Myers Squibb COM 110122108 9,854 0 0.00 633 26.60 0.3901
2019-10-30 2019-09-30 13F Bristol-Myers Squibb COM 110122108 9,854 9,854 500 0.3305
2018-02-12 2017-12-31 13F Bristol-Myers Squibb COM 110122108 0 -3,204 -100.00 0 -100.00
2017-11-09 2017-09-30 13F Bristol-Myers Squibb COM 110122108 3,204 -4,000 -55.52 204 -49.13 0.1327
2017-08-02 2017-06-30 13F Bristol-Myers Squibb COM 110122108 7,204 0 0.00 401 2.30 0.2615
2017-05-03 2017-03-31 13F Bristol-Myers Squibb COM 110122108 7,204 -2,600 -26.52 392 -31.59 0.2529
2017-02-10 2016-12-31 13F Bristol-Myers Squibb COM 110122108 9,804 0 0.00 573 8.32 0.3596
2016-11-14 2016-09-30 13F Bristol-Myers Squibb COM 110122108 9,804 -500 -4.85 529 -30.21 0.3480
2016-08-09 2016-06-30 13F Bristol-Myers Squibb COM 110122108 10,304 0 0.00 758 15.20 0.5038
2016-05-11 2016-03-31 13F Bristol-Myers Squibb COM 110122108 10,304 -200 -1.90 658 -8.99 0.4361
2016-02-05 2015-12-31 13F Bristol-Myers Squibb COM 110122108 10,504 0 0.00 723 16.24 0.4689
2015-11-12 2015-09-30 13F Bristol-Myers Squibb COM 110122108 10,504 0 0.00 622 -11.02 0.4251
2015-08-12 2015-06-30 13F Bristol-Myers Squibb COM 110122108 10,504 -800 -7.08 699 -4.12 0.4300
2015-05-07 2015-03-31 13F Bristol-Myers Squibb COM 110122108 11,304 -200 -1.74 729 7.36 0.4538
2015-02-13 2014-12-31 13F Bristol-Myers Squibb COM 110122108 11,504 0 0.00 679 15.28 0.4200
2014-11-10 2014-09-30 13F/A-1 Bristol-Myers Squibb COM 110122108 11,504 204 1.81 589 7.48 0.3843
2014-11-07 2014-09-30 13F Bristol-Myers Squibb COM 110122108 11,300 548
2014-08-12 2014-06-30 13F Bristol-Myers Squibb COM 110122108 11,300 0 0.00 548 -6.64 0.3580
2014-05-05 2014-03-31 13F Bristol-Myers Squibb COM 110122108 11,300 -2,500 -18.12 587 -19.92 0.3777
2014-02-12 2013-12-31 13F Bristol-Myers Squibb COM 110122108 13,800 0 0.00 733 14.71 0.4890
2013-11-08 2013-09-30 13F Bristol-Myers Squibb COM 110122108 13,800 0 0.00 639 3.57 0.4767
2013-08-13 2013-06-30 13F Bristol-Myers Squibb COM 110122108 13,800 13,800 617 0.4747
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.